Montal, Víctor

Victor Montal is a researcher in the field of neuroimaging and Alzheimer's disease. He has published numerous articles on cortical microstructure changes along the Alzheimer's disease continuum, including studies on autosomal-dominant Alzheimer disease and amyotrophic lateral sclerosis-frontotemporal dementia. Montal is also involved in developing methods for measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease. His research has been published in prestigious journals such as Alzheimers Dementia and Neurology.

Biography:  https://www.nature.com/articles/s41380-021-01290-z

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Identification of APOE4 as a Cause of Distinct Genetic Form of Alzheimer's Disease

Identification of APOE4 as a Cause of Distinct Genetic Form of Alzheimer's Disease

Broke On: Monday, 06 May 2024 Researchers identified that having two copies of the gene variant APOE4 reliably causes Alzheimer's disease, confirming it as a cause rather than just an increased risk factor. Nearly all individuals with this genetic makeup develop the condition by age 65, exhibiting earlier symptom onset and significantly higher levels of Alzheimer's biomarkers compared to those without the variant.